Cargando…

Invited papers - Clinical Trial Updates Session

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Invited papers - Clinical Trial Updates Session
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363549/ https://www.ncbi.nlm.nih.gov/pubmed/10939791 http://dx.doi.org/10.1054/bjoc.2000.1347

Ejemplares similares

Invited papers
Publicado: (2000)

Invited Papers 2
Publicado: (2004)

Invited Papers 1
Publicado: (2004)

Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009
por: Maier, L. S., et al.
Publicado: (2009)

Hotline sessions presented at the American College of Cardiology Congress 2009
por: Maier, Lars S., et al.
Publicado: (2009)

Updates on the Clinical Trials in Diabetic Macular Edema
por: Demirel, Sibel, et al.
Publicado: (2016)

Update on Clinical Trials in Dry Age-related Macular Degeneration
por: Taskintuna, Ibrahim, et al.
Publicado: (2016)

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
por: Laetsch, Theodore W., et al.
Publicado: (2023)

Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2010: ACCORD, INVEST, NAVIGATOR, RACE II, SORT OUT III, CSP-474, DOSE, ASPIRE and more
por: Jacobshagen, C., et al.
Publicado: (2010)

The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update
por: El-Shater Bosaily, Ahmed, et al.
Publicado: (2015)

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
por: Herbst, Roy S., et al.
Publicado: (2023)

Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial
por: Conte, PierFranco, et al.
Publicado: (2023)

Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR
por: Miyauchi, Eisaku, et al.
Publicado: (2022)

Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
por: Novello, Silvia, et al.
Publicado: (2023)

A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update
por: Makker, Vicky, et al.
Publicado: (2023)

Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
por: Makker, Vicky, et al.
Publicado: (2023)

Disasters in Europe: Inviting authors to submit scientific and practical papers on disasters in their country
Publicado: (2000)

Clinical Trials in Retinal Dystrophies
por: Grob, Seanna R., et al.
Publicado: (2016)

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
por: Lassman, Andrew B., et al.
Publicado: (2022)

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
por: Powles, Thomas, et al.
Publicado: (2023)

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
por: Deek, Matthew P., et al.
Publicado: (2022)

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
por: Rugo, Hope S., et al.
Publicado: (2023)

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS(G12C)-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases
por: Negrao, Marcelo V., et al.
Publicado: (2023)

Clinical updates on phantom limb pain
por: Erlenwein, Joachim, et al.
Publicado: (2021)

Clinical Trials in Branch Retinal Vein Occlusion
por: Panakanti, Tandava Krishnan, et al.
Publicado: (2016)

Cord pilot trial: update to randomised trial protocol
por: Bradshaw, Lucy E., et al.
Publicado: (2015)

Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial
por: Westendorp, Willeke F, et al.
Publicado: (2014)

Invited panels
Publicado: (2023)

Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan‐Hellenic, Prospective, Noninterventional Study
por: Zarifis, John, et al.
Publicado: (2015)

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
por: Armstrong, Andrew J., et al.
Publicado: (2022)

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
por: Morschhauser, Franck, et al.
Publicado: (2022)

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Pemmaraju, Naveen, et al.
Publicado: (2022)

Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study
por: Van Assche, Indra A., et al.
Publicado: (2023)

Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
por: Platzbecker, Uwe, et al.
Publicado: (2022)

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
por: de Castro, Gilberto, et al.
Publicado: (2023)

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
por: Garassino, Marina C., et al.
Publicado: (2023)

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up
por: Davies, Andrew J., et al.
Publicado: (2023)

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
por: Dy, Grace K., et al.
Publicado: (2023)

Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial
por: Bairavi, Joann, et al.
Publicado: (2023)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_47k0enc79ktoc9c69qvduf4njk